Jump to content
RemedySpot.com

Fwd: The Secrets of Effective Off-Label Compliance

Rate this topic


Guest guest

Recommended Posts

Miralax/PEG for childrenOFF-LABEL and DANGEROUSBut the FDA will tell you how to promote off label use'correctly'?????????Subject: The Secrets of Effective Off-Label Compliance

What's the difference between legal and illegal promotion of off-label uses?

Many drug and device companies don't know the right answer.

Miscues with off-label promotion are nearly always the result of weak (or nonexistent) training that assures it's only a matter of time until a promising promotion strategy turns in to a legal nightmare – a nightmare that can result in fines, criminal penalties and liability lawsuits involving millions, even billions of dollars.

Here's what you need to know NOW to avoid a call from the FDA's Office of Criminal Investigations about an off-label violation.

An FDAnews Management Report

Drug and Device Off-Label Promotion

Strategies for Regulatory Compliance and

Minimizing Liability

This report is the clearest and most practical training available today for avoiding problems with off-label promotion.

Step-by-step, in plain English, it tells what drug- and device-makers must do to navigate between legal and illegal dissemination of off-label use information ... and minimize product liability concerns.

Buy now to arm your marketing team, sales reps, training staff and others with the knowledge they need to promote your products — without the risk of off-label violations. Specifically, with this guide, you'll learn:

How off-label promotion is defined — and the regulations and penalties

that are associated with noncompliance

Real-world examples of "implicit off-label marketing traps" and how to

spot and avoid similar traps in your own promotions

What constitutes allowable vs. unallowable communications used to

discuss off-label product uses

Best practices for minimizing the risk of off-label promotion violations

Tips on creating an effective off-label promotion compliance program

and training

And more

Buy Now

Drug and Device Off-Label Promotion: Strategies for Regulatory Compliance and Minimizing Liability is offered by FDAnews in print or online in PDF format for $377.

Act now: place your order here. (Add $10 shipping and handling for printed reports shipped to the U.S. and Canada, or $35 per report shipped elsewhere. Virginia residents, please add 5 percent sales tax.)

Satisfaction Guaranteed

Your purchase is 100% guaranteed. If for any reason you decide the report is not for you, simply return the undamaged hard copy within 30 days of purchase and you'll receive a full refund (less shipping/handling). For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase to receive a refund.

Four Easy Ways to Order

Please mention priority code 11D26LT when ordering.

Order online.

Call toll free (inside the U.S.) or +1 .

Use your American Express, Visa or MasterCard.

Fax your purchase order to +1 .

Mail your check to: FDAnews, 300 N. Washington St., Suite 200

Falls Church, VA 22046-3431.

FDAnews, 300 N. Washington St., Suite 200, Falls Church, VA 22046-3431

This is a promotional message.

If you are having trouble viewing this message, click here.

Copyright © 2011 by FDAnews

Click here to unsubscribe.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...